SALVETTI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 22.403
EU - Europa 14.913
AS - Asia 13.988
SA - Sud America 2.827
AF - Africa 268
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 23
Totale 54.466
Nazione #
US - Stati Uniti d'America 22.031
CN - Cina 4.832
SG - Singapore 4.419
DE - Germania 3.201
IT - Italia 3.199
UA - Ucraina 3.001
BR - Brasile 2.403
HK - Hong Kong 1.781
PL - Polonia 1.081
RU - Federazione Russa 964
GB - Regno Unito 885
FI - Finlandia 803
IN - India 800
VN - Vietnam 777
TR - Turchia 609
IE - Irlanda 500
FR - Francia 466
SE - Svezia 278
CA - Canada 178
AR - Argentina 153
BD - Bangladesh 151
NL - Olanda 151
MX - Messico 110
ID - Indonesia 98
ZA - Sudafrica 92
JP - Giappone 79
ES - Italia 72
EC - Ecuador 71
IQ - Iraq 71
AT - Austria 68
PK - Pakistan 58
BE - Belgio 49
VE - Venezuela 47
AU - Australia 42
SA - Arabia Saudita 41
CO - Colombia 40
MA - Marocco 37
PY - Paraguay 35
IR - Iran 34
UZ - Uzbekistan 34
MU - Mauritius 32
CH - Svizzera 31
CZ - Repubblica Ceca 31
EG - Egitto 26
AE - Emirati Arabi Uniti 24
KE - Kenya 24
PE - Perù 24
CL - Cile 23
EU - Europa 23
IL - Israele 20
JM - Giamaica 19
JO - Giordania 19
AZ - Azerbaigian 15
LT - Lituania 15
TN - Tunisia 15
DZ - Algeria 14
GE - Georgia 14
PT - Portogallo 14
TT - Trinidad e Tobago 14
UY - Uruguay 13
BO - Bolivia 12
NP - Nepal 12
KZ - Kazakistan 11
PA - Panama 11
RO - Romania 11
TH - Thailandia 11
DO - Repubblica Dominicana 9
HU - Ungheria 9
HN - Honduras 8
LU - Lussemburgo 8
RS - Serbia 8
AM - Armenia 7
BB - Barbados 7
BY - Bielorussia 7
GR - Grecia 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AL - Albania 6
BG - Bulgaria 6
EE - Estonia 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
MY - Malesia 6
PS - Palestinian Territory 6
LV - Lettonia 5
MK - Macedonia 5
NO - Norvegia 5
PH - Filippine 5
AF - Afghanistan, Repubblica islamica di 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
KR - Corea 4
LK - Sri Lanka 4
OM - Oman 4
SD - Sudan 4
UG - Uganda 4
BH - Bahrain 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
Totale 54.410
Città #
Jacksonville 2.156
Singapore 2.094
Fairfield 2.065
Woodbridge 2.018
Hong Kong 1.773
Ashburn 1.760
Houston 1.441
Ann Arbor 1.127
Warsaw 1.065
Wilmington 974
Beijing 969
Cambridge 910
Princeton 906
Seattle 853
Nanjing 789
Chandler 782
Los Angeles 511
Dublin 493
New York 455
Istanbul 441
The Dalles 401
Helsinki 333
Nanchang 305
Ho Chi Minh City 286
Buffalo 271
Milan 261
Moscow 260
Munich 253
Dallas 252
Des Moines 225
Dearborn 217
São Paulo 214
Brescia 211
Changsha 194
Shenyang 193
Chicago 187
Shanghai 179
Jinan 171
Hebei 167
Tianjin 152
Hanoi 150
San Diego 141
Rome 136
San Francisco 134
Redondo Beach 128
Jiaxing 116
Kocaeli 100
Kunming 87
Hangzhou 85
Nürnberg 82
Rio de Janeiro 80
Verona 80
Lancaster 76
Toronto 76
Zhengzhou 74
Santa Clara 71
London 70
Guangzhou 68
Ningbo 66
Turku 65
Salt Lake City 63
Washington 62
Grafing 59
Haikou 59
Belo Horizonte 58
Lanzhou 58
Tokyo 55
Brooklyn 52
Taizhou 48
Florence 46
Jakarta 46
Nuremberg 46
San Mateo 45
Chennai 44
Johannesburg 43
Montreal 43
Tampa 43
Brussels 42
Phoenix 42
Denver 41
Boston 40
Orem 40
Stockholm 40
Dong Ket 39
Atlanta 37
Curitiba 37
Taiyuan 37
Brasília 35
Boardman 34
Da Nang 34
Guayaquil 34
Haiphong 33
Porto Alegre 33
Tashkent 33
Manchester 32
Mexico City 32
Poplar 32
Saint Petersburg 32
Augusta 31
Elk Grove Village 31
Totale 31.890
Nome #
Differenti metodi di calcolo della massa ventricolare sinistra e relativo significato prognostico. 1.837
Vasodilatazione flusso mediata della arteria brachiale e disfunzione endoteliale nelle piccole arterie di resistenza sottocutanee 497
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 484
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 396
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 323
Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk 297
The unusual clinical manifestation of thyroid storm. 265
Metformin-induced thyrotropin suppression is not associated with cardiac effects 257
T-wave axis deviation, metabolic syndrome and estimated cardiovascular risk in men and women of the MOLI-SANI Study 252
Vasodilatazione e vasocostrizione endotelio-dipendente nelle piccole arterie sottocutanee di pazienti con diabete di II tipo, con o senza concomitante ipertensione arteriosa. 243
T-wave axis deviation, metabolic syndrome and cardiovascular risk: results from the MOLI-SANI study 241
Carotid stiffness is significantly correlated with wall-to-lumen ratio of retinal arterioles. 228
Hypertension and stable coronary artery disease: an overview. 212
Pulsatile Hemodynamics and Microcirculation: Evidence for a Close Relationship in Hypertensive Patients. 212
[OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION 205
Left ventricular hypertrophy and renal dysfunction during antihypertensive treatment adversely affect cardiovascular prognosis in hypertensive patients. 204
Correlation between wall-to-lumen ratio of retinal arterioles and clinic and 24 hours blood pressure 204
Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. 198
Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients 193
Evaluation of Endothelial Function by Flow Mediated Dilation: Methodological Issues and Clinical Importance. 192
Inhibitors of angiogenesis and blood pressure. 192
Resistant hypertension and target organ damage. 188
Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study 182
Aterosclerosi carotidea in pazienti con iperaldosteronismo primitivo e con ipertensione arteriosa essenziale. 176
Inappropriate left ventricular mass in patients with primary aldosteronism. 175
Determinants of the structure of resistance-sized arteries in hypertensive patients. 175
Calliphora vicina human myiasis: a case report 175
ACE insertion/deletion polymorphism and cardiovascular structural phenotypes in a general population 174
Right and left ventricles: as inseparable as the twin brothers ‘Castor and Pollux’ 173
Pulse wave velocity and cardiovascular risk stratification in a general population: The Vobarno study 173
Platypnea and orthodeoxia in a patient with pulmonary embolism. 172
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 172
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 172
Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. 171
Aortic root dilatation in hypertensive patients: a multicenter survey in echocardiographic practice. 171
Assessment of target organ damage in patients with resistant hypertension 170
Treatment of hypertensive urgencies and emergencies 168
Advantages of renin inhibition in a patient with reninoma 168
Vascular Aging and Disease of the Small Vessels 168
Identification of the hemodynamic modulators and hemodynamic status in uncontrolled hypertensive patients. 167
Vasodilatazione flusso mediata dell’arteria brachiale in pazienti ipertesi: significato prognostico 164
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 163
Headache: Prevalence and relationship with office or ambulatory blood pressure in a general population sample (the Vobarno Study). 161
Arterial Blood Pressure and Cardiovascular Remodeling In Women With Previous Preeclampsia. A Case Control Study 161
Carotid structural alterations in primary aldosteronism. 160
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 160
Angiotensin II type 1 receptor A/C1166 polymorphism: relationships with blood pressure and cardiovascular structure. 157
Changes in left ventricular geometry during antihypertensive treatment 157
Association of carotid and left ventricular structure in a middle-aged general population 156
Effect of anti-hypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension. 155
Carotid atherosclerosis in patients with primary aldosteronism and with essential hypertension 155
Definitions and Epidemiological Aspects of Hypertensive Urgencies and Emergencies 155
An update on hypertensive emergencies and urgencies 152
Arterial stiffness and microcirculation evidence for a close relationship in hypertensive patients. 151
Changes of left ventricular geometry during antihypertensive treatment. A metanalysis of comparative studies in hypertensive patients 151
Relationship between wall-to-lumen ratio of retimal arterioles and clinic and 24 hours blood pressure 151
Management of VEGF-Targeted Therapy-Induced Hypertension 151
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 151
Changes in flow mediated vasodilatation during antihypertensive treatment are related to the smoothness index, but not the trough-to-peak ratio of blood pressure. 150
Arterial spontaneous rhythmic contractile activity in humans and rats: spectral analysis and regulatory mechanisms. 149
Altered endothelial function in small resistance arteries of patients with non-insulin dependent diabetes mellitus 149
Effect of Treatment With Candesartan or Enalapril on Subcutaneous Small Artery Structure in Hypertensive Patients With Noninsulin-Dependent Diabetes Mellitus. 148
WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES IS RELATED WITH CLINIC AND 24 HOURS BLOOD PRESSURE 147
Arteriall stiffness and clinic and 24 hours blood pressure in a general population. The vobarno study. 147
Carotid atherosclerosis in patients with primary aldosteronism and with essential hypertension. 146
Cardiovascular events are related to changes in left ventricular diastolic dysfunction in essential hypertension 146
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 146
Association study between genetic polymorphisms of adrenergic transmission and metabolic syndrome phenotypes. 145
Inappropriate LV mass during antihypertensive treatment adversely affects cardiovascular prognosis in hypertensive patients with left ventricular hypertrophy 145
Arterial hypertension: Unmasking the real risk 145
Changes On Left Ventricular Geometry During Long Term Anithypertensive Treatment. A Metanalysis of Comparative Studies In Hypertensive Patients 144
Evaluation of arterial stiffness in patients with sustained, isolated office and isolated ambulatory hypertension. The Vobarno study 144
The diagnosis of metabolic syndrome: an added value in the evaluation of cardiovascular risk? 144
A smartphone device for ocular fundus photography in acute hypertension 144
Relationship of wall-to-lumen ratio of retinal arterioles with clinic and 24 hours blood pressure. 144
Sindrome metabolica: un fattore di rischio cardiovascolare indipendente? 143
Longitudinal evaluation of blood pressure values and target organ damage in subjects with high normal blood pressure in a general population in Northern Italy 143
T-wave axis deviation and Left Ventricular Hypertrophy interaction in diabetes and hypertension. 143
Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension 143
Evaluation of arterial stiffness in patienyts with sustained, isolated office and isolated ambulatory hypertension. The Vobarno study. 142
Evaluation of ambulatory arterial stiffness index (AASI) and pulse wave velocity in a general population sample. The Vobarno study 142
Cardiac Rupture in a Young Male Cocaine User. 142
Hypertensive emergencies and urgencies: A single-centre experience in Northern Italy 2008-2015 141
Left ventricular mass and carotid intima media thickness are related to collagen turnover markers in essential hypertension 140
Diagnosis of metabolic syndrome: Any added value in the evaluation of cardiovascular risk? 140
Vascular remodeling, macro- and microvessels: therapeutic implications. 139
Left ventricular mass and function are related to collagen turnover markers in essential hypertension 139
Significato prognostico della vasodilatazione endotelio-dipendente nei pazienti ipertesi. 137
C-Reactive Protein level is linked to T-wave axis deviation in a healthy Italian population: results from the MOLI-SANI Project 137
ACE insertion/deletion polymorphism: is associated with carotid artery intima-media thickness, but not left ventricular mass, in a general population. 137
Prognostic role of flow mediated dilatation of the brachial artery in hypertensive patients 136
Bridging the Gap between Knowledge Representation and Electronic Health Records 136
Ocular fundus photography with a smartphone device in acute hypertension 136
Diagnosis of metabolic syndrome: any added value in the evaluation of cardiovascular risk? 135
Interactions Between Macro- and Micro-Circulation: Are They Relevant? 135
Therapeutic Approach to Hypertensive Emergencies: Hemorrhagic Stroke 135
Morte cardiaca improvvisa di una ragazza di 14 anni con familiarità per cardiomiopatia aritmogena dl ventricolo sinistro (LDAC): un approccio multidisciplinare. 135
Il concetto di sindrome metabolica: un valore aggiunto nella valutazione del rischio cardiovascolare? 134
Arterial Stiffness In Apolipoprotein A-i (leu75pro). A Case-control Study 134
Correlation between clinic and 24 hours blood pressure and wall-to-lumen ratio of retinal arterioles 134
Totale 19.174
Categoria #
all - tutte 250.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.169 0 0 0 0 0 725 207 738 898 616 769 216
2021/20223.687 143 655 60 154 122 246 225 318 208 401 347 808
2022/20232.932 557 95 57 210 251 804 30 235 376 41 132 144
2023/20243.477 183 81 240 269 185 527 202 172 938 87 79 514
2024/20259.085 172 77 115 982 1.110 651 971 302 924 777 1.906 1.098
2025/202610.073 1.557 2.224 1.311 2.516 1.553 912 0 0 0 0 0 0
Totale 55.067